Literature DB >> 22656890

Ophthalmic generics--are they really the same?

Wiley A Chambers.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22656890     DOI: 10.1016/j.ophtha.2012.03.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

1.  [Original preparations versus generics--latanoprost: how similar is different?].

Authors:  M A Leitritz; H-P Lipp; B Voykov; F Ziemssen
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

2.  Influence of Manufacturing Process Variables on the Properties of Ophthalmic Ointments of Tobramycin.

Authors:  Shilpa Patere; Bryan Newman; Yan Wang; Stephanie Choi; Sahil Vora; Anson W K Ma; Michael Jay; Xiuling Lu
Journal:  Pharm Res       Date:  2018-07-25       Impact factor: 4.200

Review 3.  Evaluation of Physical Properties of Generic and Branded Travoprost Formulations.

Authors:  Meenakshi Wadhwani; Sanjay K Mishra; Dewang Angmo; Thirumurthy Velpandian; Ramanjit Sihota; Ankita Kotnala; Shibal Bhartiya; Tanuj Dada
Journal:  J Curr Glaucoma Pract       Date:  2016-08-05

Review 4.  Generics versus brand-named drugs for glaucoma: the debate continues.

Authors:  Shibal Bhartiya; Deepika Dhingra
Journal:  Rom J Ophthalmol       Date:  2020 Jul-Sep

5.  Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin.

Authors:  Elisa Toropainen; Sara J Fraser-Miller; Dunja Novakovic; Eva M Del Amo; Kati-Sisko Vellonen; Marika Ruponen; Tapani Viitala; Ossi Korhonen; Seppo Auriola; Laura Hellinen; Mika Reinisalo; Unni Tengvall; Stephanie Choi; Mohammad Absar; Clare Strachan; Arto Urtti
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.